COMMON STOCK PURCHASE WARRANT EYEGATE PHARMACEUTICALS, INC.Common Stock Purchase Warrant • April 13th, 2018 • Eyegate Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “ Holder ”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [___]1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from EyeGate Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 31st, 2019 • Eyegate Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 31, 2019, between EyeGate Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
INDEX TO AMENDED AND RESTATED LOAN AGREEMENTLoan Agreement • October 28th, 1998 • Cornerstone Brands Inc • Retail-catalog & mail-order houses • Massachusetts
2- 4 to the Representative, as agent for the Sellers, to (i) pay the SMI Transaction Expense Payments (as defined in Section 10.11) and (ii) to disburse the remaining amount, after payment of all such SMI Transaction Expense Payments by the...Purchase Agreement • September 21st, 1998 • Dial Corp /New/ • Soap, detergents, cleang preparations, perfumes, cosmetics • New York
ASSET PURCHASE AGREEMENT ------------------------Asset Purchase Agreement • December 5th, 1997 • View Tech Inc • Wholesale-electronic parts & equipment, nec • Massachusetts
P R E M I S E SAsset Purchase Agreement • March 27th, 2003 • Getty Realty Corp /Md/ • Real estate • Massachusetts
RECITALS --------Settlement Agreement • January 21st, 2000 • Response Usa Inc • Services-miscellaneous business services • New York
UNDERWRITING AGREEMENT between COMSTOCK MINING INC. and AEGIS CAPITAL CORP., as Representative of the Several UnderwritersUnderwriting Agreement • March 31st, 2016 • Comstock Mining Inc. • Gold and silver ores • New York
HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC. (a Delaware corporation) Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 20th, 2013 • Harvard Apparatus Regenerative Technology, Inc. • Surgical & medical instruments & apparatus • New York
EXECUTION VERSION SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of January 31, 2024, between Kiora Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the...Securities Purchase Agreement • February 1st, 2024 • Kiora Pharmaceuticals Inc • Pharmaceutical preparations • New York
among USTELECENTERS, INC., as the BorrowerCredit Agreement • February 5th, 1998 • View Tech Inc • Wholesale-electronic parts & equipment, nec
BY AND AMONGStock Purchase Agreement • October 13th, 1999 • Response Usa Inc • Services-miscellaneous business services • Delaware
ARTICLE IMerger Agreement • November 4th, 2003 • Adstar Inc • Services-business services, nec • California
INDENTUREIndenture • November 15th, 1999 • Uici • Fire, marine & casualty insurance • New York
LOAN AGREEMENTLoan Agreement • March 27th, 1998 • Sonesta International Hotels Corp • Hotels & motels • Florida
KIORA PHARMACEUTICALS, INC. and VSTOCK TRANSFER, LLC, as Warrant Agent Warrant Agency Agreement Dated as of _________, 2022 WARRANT AGENCY AGREEMENTWarrant Agency Agreement • July 13th, 2022 • Kiora Pharmaceuticals Inc • Pharmaceutical preparations • New York
WARRANT AGENCY AGREEMENT, dated as of __________, 2022 (“Agreement”), by and between Kiora Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and VStock Transfer, LLC, a New York limited liability trust company (“VStock” or the “Warrant Agent”).
EXHIBIT 2.2 PREFERRED STOCK PURCHASE AGREEMENT dated as of November 22, 1996 between CORNERSTONE PROPERTIES INC., a Nevada corporation (the "Company"), the NEW YORK STATE TEACHERS' RETIREMENT SYSTEM (the "Purchaser").- WHEREAS, the Company wishes to...Preferred Stock Purchase Agreement • December 12th, 1996 • Cornerstone Properties Inc • Real estate • New York
AT THE MARKET OFFERING AGREEMENTAt the Market Offering Agreement • December 23rd, 2022 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
1,447,628 SHARES OF COMMON STOCK, 3,908 SHARES OF SERIES F CONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO 3,552,372 SHARES OF COMMON STOCK) AND 5,000,000 CLASS C WARRANTS (EXERCISABLE FOR 5,000,000 SHARES OF COMMON STOCK) 5,000,000 CLASS D WARRANTS...Underwriting Agreement • June 6th, 2023 • Kiora Pharmaceuticals Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 13th, 2023 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of [____], 2023, between Sonoma Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 17th, 2024 • Harvard Apparatus Regenerative Technology, Inc. • Surgical & medical instruments & apparatus • Massachusetts
This Securities Purchase Agreement (this “Agreement”) is dated as of April 15, 2024, between Harvard Apparatus Regenerative Technology, Inc., a Delaware corporation (the “Company”), and [_____________] (the “Purchaser”).
FORM OF WARRANT] KUSHCO HOLDINGS, INC. Warrant To Purchase Common StockWarrant Agreement • January 16th, 2019 • KushCo Holdings, Inc. • Miscellaneous plastics products • New York
KushCo Holdings, Inc., a Nevada corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, _________________, the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Common Stock (including any Warrants to purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), _________________ (subject to adjustment as provided herein) fully paid and non-assessable shares of Common Stock (as defined below) (the “Warrant Shares”, and such number of Warrant Shares, the “Warrant Number”). Except as otherwise defined herein, capitalized terms in this Warran
Sonoma Pharmaceuticals, Inc. Shares of Common Stock (par value, $0.0001 per share) EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • December 18th, 2023 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Sonoma Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC, as exclusive sales agent (the “Agent”), shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”), with the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”, on terms set forth herein and subject to the limitations set forth in Section 2 hereof. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
ARTICLE I SALE AND PURCHASE OF BUSINESS AND ASSETSAsset Purchase Agreement • January 9th, 1997 • Alden Electronics Inc • Telephone & telegraph apparatus • Massachusetts
FINANCING AGREEMENT Dated as of January 31, 2018 by and among HARVARD BIOSCIENCE, INC., as Parent and as Borrowing Agent, PLYMOUTH Sub, Inc. (to be merged with and into Data Sciences International, Inc.) AND EACH OTHER SUBSIDIARY OF PARENT LISTED AS A...Financing Agreement • February 2nd, 2018 • Harvard Bioscience Inc • Laboratory analytical instruments
Financing Agreement, dated as of January 31, 2018, by and among Harvard Bioscience, Inc., a Delaware corporation, a borrower (the "Parent" or the "Borrowing Agent"), Plymouth Sub, Inc., a Delaware corporation and directly wholly-owned subsidiary of the Parent, a borrower ("Merger Sub" or, prior to the consummation of the Acquisition (as defined herein), the "Initial Borrower"), which shall be merged with and into Data Sciences International, Inc., a Delaware corporation (the "Target" or, immediately upon consummation of the Acquisition, the "Surviving Borrower"), each of the other Borrowers (as defined herein) and Guarantors (as defined herein) from time to time party hereto, the lenders from time to time party hereto (each a "Lender" and collectively, the "Lenders"), Cerberus Business Finance, LLC, a Delaware limited liability company ("CBF"), as collateral agent and hypothecary representative for the Secured Parties (in such capacity, together with its successors and assigns in such
FORM OF AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 3rd, 2023 • Monterey Capital Acquisition Corp • Blank checks • New York
THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2023, is made and entered into by and among Monterey Capital Acquisition Corporation, a Delaware corporation (the “Company”), Monterrey Acquisition Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), certain equityholders of ConnectM Technology Solutions, Inc., a Delaware corporation (“ConnectM”), set forth on Schedule A (such equityholders, the “ConnectM Holders”), and certain equityholders of the Company set forth on Schedule B (such equityholders, including the Sponsor, the “Sponsor Holders” and, collectively with the ConnectM Holders, and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement are each referred to herein as a “Holder” and collectively as the “Holders”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 24th, 2009 • General Steel Holdings Inc • Steel works, blast furnaces & rolling & finishing mills • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 24, 2009, between General Steel Holdings, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
RECITALSEnvironmental Indemnity Agreement • March 28th, 1997 • Sonesta International Hotels Corp • Hotels & motels • Massachusetts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 10th, 2010 • General Steel Holdings Inc • Steel works, blast furnaces & rolling & finishing mills • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 24, 2009, between General Steel Holdings, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
CREDIT AGREEMENTCredit Agreement • December 4th, 2015 • TRC Companies Inc /De/ • Services-engineering services • New York
This CREDIT AGREEMENT is entered into as of November 30, 2015 among the following: (i) TRC COMPANIES, INC., a Delaware corporation (the “Borrower”); (ii) the lenders from time to time party hereto (each a “Lender” and collectively, the “Lenders”); (iii) CITIZENS BANK, N.A., as the administrative agent (the “Administrative Agent”), an LC Issuer (as hereinafter defined), the Swingline Lender (as hereinafter defined), and as the sole lead arranger and sole bookrunner (in such capacity, the “Arranger”), (iv) BMO HARRIS BANK N.A., as the Syndication Agent and an LC Issuer, and (v) KEYBANK, NATIONAL ASSOCIATION, as the Documentation Agent.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 3rd, 2018 • Biostage, Inc. • Surgical & medical instruments & apparatus • Massachusetts
This Securities Purchase Agreement (this “Agreement”) is dated as of December 27, 2017, between Biostage, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
AMONGMerger Agreement • October 4th, 1996 • View Tech Inc • Wholesale-electronic parts & equipment, nec • California
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • August 14th, 2000 • Zoom Telephonics Inc • Telephone & telegraph apparatus • Massachusetts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 3rd, 2018 • Biostage, Inc. • Surgical & medical instruments & apparatus • Massachusetts
This Securities Purchase Agreement (this “Agreement”) is dated as of May 1, 2018, between Biostage, Inc., a Delaware corporation (the “Company”), and Chu Bogang (the “Purchaser”).
HARVARD APPARATUS REGENERATIVE TECHNOLOGY, inc. 1,800,000 SHARES OF COMMON STOCK AND 695,857 SHARES OF SERIES b CONVERTIBLE PREFERRED STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • February 12th, 2015 • Harvard Apparatus Regenerative Technology, Inc. • Surgical & medical instruments & apparatus • New York
Harvard Apparatus Regenerative Technology, Inc., a Delaware corporation (the “Company”) proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule VI hereto (the “Underwriters”), for whom National Securities Corporation is acting as representative (the “Representative”), an aggregate of 1,800,000 authorized but unissued shares (the “Firm Shares”) and, at the election of the Underwriters, up to 270,000 additional shares (the “Additional Shares”) of common stock, par value $0.01 per share (the “Common Stock”) of the Company, in an offering under its registration statement on Form S-3 (File No. 333-200926) (the Firm Shares and the Additional Shares the Underwriters elect to purchase pursuant to Section 3 hereof being collectively called the “Offered Shares”) and an aggregate of 695,857 shares of Series B Convertible Preferred Stock, par value $0.01 per share, (the “Preferred Stock”) of the Company. The 3,479,285 shares of the Compa
